Lead Opinion
AMENDED OPINION
OPINION
I. FACTUAL AND PROCEDURAL HISTORY
On August 2, 2002, AmerisourceBergen Corporation
On May 30, 2003, AmerisourceBergen filed a reply to Dialysist West’s counterclaim conceding that it had not paid for the non-Epogen products (including Procrit) and that these products were genuine. On July 22, 2003, Dialysist West filed a motion for judgment on the pleadings and for entry of final judgment pursuant to Federal Rule of Civil Procedure 54(b) on the $2.2 million counterclaim. On August 25, 2003, AmerisourceBergen filed a cross-motion for leave to amend its complaint and its reply to Dialysist West’s counterclaim, changing its tack by alleging that Dialysist West had also sold it counterfeit Procrit. On January 6, 2004, the district court granted Dialysist West’s motion for judgment on the pleadings, denied Amerisour-ceBergen’s motion for leave to amend, and certified the judgment as final under Rule 54(b). On March 3, 2004, the district court denied AmerisourceBergen’s motion to stay execution of judgment and Ameri-sourceBergen filed this appeal on March 24, 2004.
II. JURISDICTION & STANDARD OF REVIEW
We have subject matter jurisdiction over the final decision of the district court pursuant to 28 U.S.C. § 1291. We review the district court’s interpretation of Arizona contract law de novo. El-Hakem v. BJY Inc.,
III. DISCUSSION
A. Setoff of Epogen Claims
AmerisourceBergen claims that the district court erred in finding that it could not set-off the approximately $2.2 million it owes Dialysist West for non-Epogen, pharmaceutical purchases against the estimated $8 million judgment it seeks from Dial-ysist West for selling AmerisourceBergen counterfeit Epogen. AmerisourceBergen bears the burden of establishing that it is entitled to either a legal or equitable setoff of its claims. See Newbery Corp. v. Fireman’s Fund Ins. Co.,
AmerisourceBergen and Dialysist West agree that section 47-2717 of the Arizona Commercial Code applies. The Arizona statute, a codification of section 2-717 of the Uniform Commercial Code, provides:
The buyer on notifying the seller of his intention to do so may deduct all or any part of the damages resulting from any breach of the contract from any part of the price still due under the same contract.
Ariz.Rev.Stat. § 47-2717 (2006). A plain reading of the statute indicates that a party may not set-off a contractual claim against a debt on a separate contract. See ITV Direct, Inc. v. Healthy Solutions, LLC,
AmerisourceBergen concedes that the contracts for sale of Epogen and the other drugs were separate contracts. But because the Vendor Agreement signed by Dialysist West permits AmerisourceBer-gen to return any goods to Dialysist West for “full credit,” AmerisourceBergen believes it was justified in applying the credit it held for the counterfeit Epogen purchases against its outstanding debts. Am-erisourceBergen’s reading of the Vendor Agreement is strained.
The contract clause is not ambiguous, as AmerisourceBergen argues. The intention of the parties is clear: to create a return policy by which AmerisourceBergen can fully recover for returned goods that do not meet its standards. See Smith v. Melson, Inc.,
Furthermore, AmerisourceBergen has provided no evidence that it was the pattern or practice of the parties or industry custom to offset deficiencies in one sales contract by giving discounts or “credit” on other sales contracts. See Mohave Valley Irrigation & Drainage Dist. v. Norton,
AmerisourceBergen argues that even if it is not entitled to offset its debt under section 47-2717 of the Arizona Commercial Code, Dialysist West’s insolvency affords it an equitable right of setoff under Arizona common law. But Amerisource-Bergen’s claim to equitable setoff is preempted by 47-2717. Arizona’s Commercial Code provides that “principles of law and equity” apply “unless [displaced] by the particular provisions of this title.” Ariz.Rev.Stat. § 47-1103 (2006); see also John Deere Co. v. First Interstate Bank,
B. Denial of Leave to Amend
AmerisourceBergen appeals the district court’s decision to deny it leave to amend its reply pursuant to Federal Rule of Civil Procedure 15(a).
AmerisourceBergen filed its leave to amend on August 25, 2003, nearly fifteen months after it first learned that counterfeit Procrit was in the marketplace and three months after entering a reply where it conceded that the products for which it had not paid Dialysist West, including Procrit, were genuine. In the dissent, Judge Tashima emphasizes the district court’s filing of a pretrial scheduling order on July 7, 2003, which extended the period for filing a motion to amend from June 2, 2003 to December 2, 2003; and the non-expert discovery cutoff date from August 1, 2003 to February 2, 2004.
By the dissent’s reasoning, a district court initially has the discretion to determine whether a motion for leave to amend is prejudicial, made in bad faith, would cause undue delay, or is futile under Rule 15(a); but once the district court sets a schedule for pretrial motions pursuant to Rule 16(b), the court must accept all “timely” motions filed before the court-appointed deadline.
Federal Rule of Civil Procedure 16 has no effect on the operation of Federal Rule of Civil Procedure 15(a) principles in this case. In Johnson v. Mammoth Recreations, Inc.,
Unlike the district courts in Halbert and DCD Programs,
In assessing timeliness, we do not merely ask whether a motion was filed within the period of time allotted by the district court in a Rule 16 scheduling order. Rather, in evaluating undue delay, we also inquire “whether the moving party knew or should have known the facts and theories raised by the amendment in the original pleading.” Jackson,
In this case, fifteen months passed between the time AmerisourceBergen first discovered the possibility that the Procrit was tainted and its assertion of this theory in the motion for leave to amend. Even more detrimental to AmerisourceBergen’s motion for leave to amend, however, is the fact that AmerisourceBergen had admitted only three months before that the products for which it had not paid Dialysist West, including Procrit, were genuine. At the time AmerisourceBergen filed its reply in May 2003, it had all the information necessary to raise the affirmative defense it now pursues: AmerisourceBergen knew about the counterfeit Procrit on the pharmaceuticals market, acknowledged that it had purchased Procrit from Dialysist West during that period, and had previously filed suit because it believed that it had purchased counterfeit drugs from Dialysist West. Although AmerisourceBergen vigorously protests the denial of its motion for leave to amend, it has never provided a satisfactory explanation of why, twelve months into the litigation, it so drastically changed its litigation theory.
Even though eight months of discovery remained, requiring the parties to scramble and attempt to ascertain whether the Procrit purchased by AmerisourceBergen was tainted, would have unfairly imposed potentially high, additional litigation costs on Dialysist West that could have easily been avoided had AmerisourceBergen pursued its “tainted product” theory in its original complaint or reply.
C. Certification of Final Judgment
AmerisourceBergen also appeals the district court’s certification of final judgment on Dialysist West’s counterclaim under Federal Rule of Civil Procedure 54(b). Rule 54(b) provides that final entry of judgment should be made on individual claims in multiple claim suits “upon an express determination that there is no just reason for delay.” Fed.R.Civ.P. 54(b). Review of a district court’s certification of a final judgment involves a two-step process. See Curtiss-Wright Corp. v. Gen. Elec. Co.,
The district court found that there was no risk of duplicative effort by the courts because any subsequent judgments in this case would not vacate its judgment on Dialysist West’s counterclaim. See Curtiss-Wright,
AmerisourceBergen contends that, as a matter of equity, the district court’s certification of its judgment on Dialysist West’s counterclaim should not be upheld because Dialysist West is insolvent. We recognize that insolvency is a factor that should weigh against the final entry of judgment on Dialysist West’s counterclaim. See Reiter v. Cooper,
In weighing the equities of Rule 54(b) certification, the district court concluded that certification was warranted because this result: (1) aligned with the setoff
“The task of weighing and balancing the contending” equities of a case is “peculiarly one for the trial judge.” Curtiss-Wright,
D. Denial of Stay of Enforcement
Federal Rule of Civil Procedure 62(h) provides that when a court has entered final judgment, it may upon its discretion, “stay enforcement of that judgment until the entering of a subsequent judgment or judgments.” Fed.R.Civ.P. 62(h). AmerisourceBergen argues that the district court erred in rejecting its 62(h) motion by conflating Rule 54(b) and Rule 62(h). While it is true that the district court has discretion to grant a stay when it has already certified final judgment,
AmerisourceBergen cannot show that failure to provide the stay will cause it to suffer greater harm than Dialysist West will face should it be denied this judgment pending resolution of AmerisourceBer-gen’s outstanding claims. See Soo Line R.R. Co. v. Escanaba & Lake Superior R.R. Co.,
E. Attorney’s Fees & Costs of Appeal
Dialysist West seeks attorney’s fees and the costs of appeal under Arizona Revised Statute section 12-341.01(A). The statute permits an award of attorney’s fees to the “successful party” in “any contested action arising out of a contract.” Ariz.Rev.Stat. § 12-341.01(A) (2006). An award of attorney’s fees under Arizona law is permissive, rather than mandatory. See Wagenseller v. Scottsdale Mem’l. Hosp.,
(1) whether the unsuccessful party’s claim or defense was meritorious; (2) whether the litigation could have been avoided or settled and the successful party’s efforts were completely superfluous in achieving the result; (3) whether assessing fees against the unsuccessful party would cause an extreme hardship; (4) whether the successful party prevailed with respect to all of the relief sought; (5) whether the legal question presented was novel and whether such claim or defense have previously been adjudicated in this jurisdiction; and (6) whether the award would discourage other parties with tenable claims or defenses from litigating or defending legitimate contract issues for fear of incurring liability for substantial amounts of attorney’s fees.
Id. at 1049. Neither party directly addresses the Wagenseller factors in its briefing, but there is sufficient evidence in the record to conclude that these factors weigh against granting Dialysist West attorney’s fees and costs. First, no evidence has been presented indicating that this ease could have been successfully avoided or settled. Second, the issues in this appeal raise novel questions of contract law. Finally, we do not wish to discourage parties like AmerisourceBergen from litigating opaque issues of contract law for fear of being saddled with opposing counsel’s fees and costs.
AFFIRMED.
Notes
. AmerisourceBergen Corp. succeeded Bergen Brunswig Corporation as the plaintiff-appellant in this case.
. The relevant contract clause reads: “BBC may, at its sole option, return all or any part of any product received from Vendor and receive full credit for all returned items.”
. We need not decide whether the district court also erred in denying AmerisourceBer-gen leave to amend its complaint. See 10 Moore’s Federal Practice, § 54.28[3][b], at 54-109 (3d ed. 2005) (“On appeal of a judgment properly entered under Rule 54(b), the court of appeals may review any matter implicated by the judgment, but should not reach beyond the bounds of the judgment.... ”).
. In a joint motion to extend the dates set in the pretrial schedule, counsel for the parties argued that more time was necessary because of disputes regarding what materials should be produced and the complications that arose in the case from the entry of third parties. Joint Motion To Extend Dates in Pretrial Schedule, Bergen Brunswig Corp. v. Dialysist West, Inc., No. CIV 02 1472 PHX JWS, at *3 (D. Ariz. June 19, 2003).
.Judge Tashima's interpretation of Halbert is flawed. Halbert does not stand for the proposition that a district court must always accept a motion for leave to amend simply because the court has established a period, pursuant to Federal Rule of Civil Procedure 16(b), in which the parties may file a leave to amend. Rather, Halbert reiterates that granting or denying a motion for leave to amend remains within the discretion of the district court. Halbert,
. Judge Tashima argues that it would be pointless to create a schedule for filing pretrial motions pursuant to Federal Rule of Civil Procedure 16(b), "if the schedule can be disregarded by the court and counsel.” Dissent at 958 n. 1.
. AmerisourceBergen Corp., et al. v. Dialysist West, Inc., No. CIV-02-1472-PHXJWS, slip op. at 6 (D.Ariz. Jan. 6, 2004) ("The effect of filing a motion to amend prior to court ordered deadlines is that Rule 15(a) provides the standard of review, not the ‘good cause' standard articulated in Rule 16.”)
. Halbert,
. AmerisourceBergen, No. CIV-02-1472-PHXJWS, slip op. at 4-7. The district court's key holdings on the motion for leave to amend were: 1) AmerisourceBergen did not allege any "newly discovered facts” in the motion nor did the company explain why it waited over a year after filing its complaint before bringing these facts to the attention of the court; and 2) the amendments were prejudicial because they contradicted the company’s "own previous admissions mid-stream,” without any proffered reason.
. See 6 Charles Alan Wright, Arthur R. Miller & Mary Kay Kane, Federal Practice and Procedure § 1487 (2d ed.1990) (stating that "if [an] ... amendment substantially changes the theory on which the case has been proceeding and is proposed late enough so that the opponent would be required to engage in significant new preparation, the court may deem it prejudicial.”).
. See Curtiss-Wright,
. Judge Tashima would stay enforcement of the judgment and "protect[] AmerisourceBer-gen's claims against Dialysist West's insolvency.” Dissent at 17343. Section 553 of the Bankruptcy Code governs the equitable right of setoff in bankruptcy law. 11 U.S.C. § 553 (2006). Section 553, however, does not create a right of setoff: "Rather, the section merely recognizes and preserves setoff rights that exist under other applicable law. Thus, the threshold determination in every case involving section 553 is the source of the alleged setoff right.” 5 Myron M. Sheinfeld et al., Collier on Bankruptcy ¶ 553.01 [2] (Lawrence P. King, ed., 15th ed. rev.2005). Ameri-sourceBergen has no right to legal or equitable setoff under Arizona law for the judgment against it on the counterclaim; it therefore does not have a right to setoff under bankruptcy law. See In re HAL, Inc.,
Dissenting Opinion
dissenting.
While I agree with most of the majority’s disposition of the issues raised by this appeal, I part company on two issues. I believe that the district court abused its discretion in denying AmerisourceBergen’s motion for leave to amend because the motion was made well before the deadline set by the court for the making of such motions and because Dialysist West has shown absolutely no prejudice. I further believe that the district court abused its
1. Leave to Amend.
Federal Rule of Civil Procedure 15 provides that “leave to amend shall be freely given when justice so requires.” Fed. R.Civ.P. 15(a). Absent prejudice, or a “strong showing” of the other factors, such as undue delay, bad faith, or dilatory motive, “there exists a presumption under Rule 15(a) in favor of granting leave to amend.” Eminence Capital, LLC v. Aspeon, Inc.,
On January 16, 2003, the district court held the scheduling conference, pursuant to Federal Rule of Civil Procedure 16, and set the trial date and the deadlines for discovery and dispositive motions. On June 19, 2003, the parties filed a joint motion to extend the dates in the pretrial schedule. The district court granted the motion on July 7, 2003, and accordingly filed an order adjusting the pretrial schedule, based on the joint motion of the parties and on a showing of good cause. This order provided that the last date to file motions to amend was extended from June 2, 2003, to December 2, 2003. The order also extended the non-expert discovery cutoff date from August 1, 2003, to February 2, 2004, and for expert discovery from October 17, 2003, to April 19, 2004. The court deleted the reference to the pretrial conference, stating that it would address the final pretrial arrangements at a later date. AmerisourceBergen’s motion for leave to amend was filed on August 25, 2003 — more than three months before the cutoff date for such motions and almost eight months before discovery was to be completed.
“A pretrial order controls the subsequent course of the ction unless modified ‘upon a showing of good cause.’ ” El-Hakem v. BJY Inc.,
We have often affirmed the denial of leave to amend when the motion was made after the cutoff date for such motions, or when discovery had closed or was about to close. For example, in Zivkovic, the motion to amend was filed three months after the deadline established by the court and only five days before discovery was to be completed. We concluded that, under those circumstances, the district court did
Our jurisprudence thus establishes that where a motion to amend the pleadings is made within the time established by the pretrial scheduling order for the making of such motions, the motion is presumptively timely. Otherwise, it would be a pointless exercise to establish cutoff dates in a Rule 16 scheduling order.
The majority has cited no case in which a motion to amend was made within the deadline set by the district court and yet denied as untimely. Indeed, such a case would be difficult to find because common sense and Rule 16 dictate that a motion filed “well within the ... scheduling order deadline for the amendment of pleadings” is timely “on its face.” Id.
Contrary to the majority’s assertion, taking into account the fact that the motion was presumptively timely does not force the district court to “accept all ‘timely’ motions filed before the court-appointed deadline.”
In DCD Programs, Ltd. v. Leighton,
The Eighth Circuit similarly has relied on the fact that trial was nearly three months away in concluding that the district court abused its discretion in denying leave to amend an answer. Dennis v. Dillard Dep’t Stores, Inc.,
Similar to DCD, the trial date in the instant case had not even been set at the time AmerisourceBergen filed its motion to amend. The district court already had found that there was good cause to modify the pretrial schedule, giving the parties six additional months to file motions to amend, to complete discovery, and to file disposi-tive motions. AmerisourceBergen’s motion was filed less than two months after the court had modified the schedule, and well before the deadline established by the modified schedule. Thus, this case falls squarely within the reasoning of DCD, Dennis, and Halbert.
The majority asserts that this case is distinguishable from DCD and Halbert because the district court provided sufficient reasons to justify the denial of the leave to amend. Maj. op. at 953. The district court relied primarily on a finding of prejudice to Dialysist West in denying the motion to amend, but the court did not explain how Dialysist West would be prejudiced. We have noted that “[b]ald assertions of prejudice cannot overcome the strong policy reflected in Rule 15(a) to ‘facilitate a proper disposition on the merits.’ ” Hurn v. Ret. Fund Trust of the Plumbing, Heating & Piping Indus.,
The majority asserts that the proposed amendment would have imposed “potentially high, additional litigation costs on Dialysist West.”
The reason the majority gives for the potential additional litigation costs is that AmerisourceBergen “drastically changed its litigation theory.” Maj. op. at 953. Yet AmerisourceBergen alleged in its proposed amendment that it purchased both Epogen and Procrit from Dialysist West, the two are identical drugs, they are manufactured by the same company, although Procrit is
Dialysist West bore the burden of showing that it would be prejudiced by the proposed amendment. See Eminence Capital,
As in DCD and Dennis, I would therefore hold that Dialysist West has failed to demonstrate any prejudice from the proposed amendment, let alone prejudice sufficient to overcome the presumption in favor of granting leave to amend. See, e.g., Adam v. Hawaii,
The district court also stated that Amer-isourceBergen’s proposed amendment sought to contradict established facts of the case. The majority similarly relies on this reasoning. See Maj. Op. at 952-953. But this is the very nature and purpose of an amendment. “ ‘[A]n amended pleading supersedes the original.’ ” Armstrong v. Davis,
Finally, the majority asserts that permitting the amendment “would have unfairly delayed Dialysist West’s collection of a judgment worth over $2.2 million.” Maj. op. at 953-954.
There is nothing in the record, however, to support the assertion that final judgment would have been unnecessarily delayed. The pretrial conference date had previously been vacated and no trial date had been set, and there was ample time left before the discovery cutoff date to conduct any necessary discovery. Thus, nothing in this record supports the majority’s assertion of unnecessary delay.
The district court abused its discretion in denying AmerisourceBergen’s timely motion to amend in the absence of any showing of prejudice by Dialysist West.
2. Stay of the Judgment.
I also believe that the district court abused its discretion in denying Ameri-sourceBergen’s motion to stay the judgment pursuant to Rule 62(h). After directing entry of final judgment pursuant to Rule 54(b) against AmerisourceBergen on Dialysist West’s second claim for relief in its counterclaim, the district court denied AmerisourceBergen’s motion to stay the judgment pursuant to Rule 62(h). To support its order, the district court stated only that AmerisourceBergen’s motion was based on Dialysist West’s insolvency, and that it had considered the issue in its prior order and found the argument unpersuasive. But the insolvency analysis under Rule 62(h) is different from the insolvency analysis under Rule 54(b), and the district court did not make that analysis.
This case involved several claims and counterclaims. The district court directed entry of judgment on the pleadings with respect to Dialysist West’s second claim for relief in its counterclaim, related to non-Epogen products. Still at issue are AmerisourceBergen’s claims regarding Epogen and Dialysist West’s first claim for relief. Although the district court ruled against AmerisourceBergen on the setoff issue, AmerisourceBergen’s claim regarding the counterfeit Epogen remains. Am-erisourceBergen argued below that enforcement of the judgment should be stayed because of Dialysist West’s insolvency. The district court docket indicates that Dialysist West had, in fact, filed for bankruptcy as of May 2004.
In Curtiss-Wright Corp. v. General Electric Co.,
The Supreme Court again cited the threat of insolvency in Reiter v. Cooper,
The district court here denied Ameri-sourceBergen’s motion to stay enforcement of the judgment without any discussion, stating only that it had considered AmerisourceBergen’s argument regarding Dialysist West’s insolvency when it granted Dialysist West’s motion for judgment on the pleadings, and citing its prior order. But the discussion cited by the district court regarding Dialysist West’s “alleged threat of insolvency” was made in the context of AmerisourceBergen’s argument that it was entitled to equitable setoff because of Dialysist West’s insolvency, which is a completely different question from that raised by the motion under Rule 62(h).
AmerisourceBergen sought a stay of the enforcement of the judgment because of Dialysist West’s undisputed insolvency and the claims that remained to be resolved. The Supreme Court’s references to Rule 62(h) in Curtiss-Wright and Reiter indicate that the instant case presents exactly the type of situation in which a stay of the enforcement of the judgment is appropri
The majority reasons that staying the judgment would “effectively sanction” Am-erisourceBergen’s “self-help tactics” because, if it succeeds on its Epogen claim, it “will have avoided paying funds it owes Dialysist West and would unjustifiably leap-frog other creditors.” Maj. op. at 956.
AmerisourceBergen cannot continue to litigate its Epogen claim, however, because Dialysist West has filed for bankruptcy and, pursuant to 11 U.S.C. § 362(a)(1), the case has been stayed by the district court. See 11 U.S.C. § 362(a) (stating that a bankruptcy petition operates as a stay of, inter alia, the continuation of a judicial proceeding against the debtor that was commenced prior to the bankruptcy filing); McCarthy, Johnson & Miller v. North Bay Plumbing, Inc. (In re Petitit),
As discussed supra, Curtiss-Wright and Reiter indicate that, when multiple claims and counterclaims are involved, and the district court grants certification under Rule 54(b), “valid considerations of economic duress and solvency” can be addressed by the use of Rule 62(h) to “protect all parties.” Curtiss-Wright,
Because the district court failed to conduct any analysis of AmerisourceBergen’s Rule 62(h) motion and did not consider the effect of Dialysist West’s insolvency on its ability to satisfy any claims of Amerisour-ceBergen, I believe that the court abused its discretion in denying the Rule 62(h) motion.
For the foregoing reasons, I would reverse the judgment of the district court. I respectfully dissent.
. What would be the point, for example, of the rule’s requirement that "[a] schedule shall not be modified except upon a showing of good cause and by leave of the district court,” Fed.R.Civ.P. 16(b), if the schedule can be disregarded by the court and counsel.
. The majority’s use of quotation marks around "timely” is disingenuous; there is absolutely no question that the motion to amend was timely.
. There is no denying that litigation costs today are high. But if the "high cost" of additional litigation were a sufficient showing of prejudice, then virtually all but the most innocuous amendments could be denied as "prejudicial.” This surely cannot be the standard for denying leave to amend.
. In its memorandum in support of its motion to amend, AmerisourceBergen disputed Dialy-sist West's assertions regarding the need for further discovery that would arise from the proposed amendment.
. The majority apparently believes that the only right of AmerisourceBergen protectable by a stay is its equitable right of setoff. Maj. op. at 956 n. 12. This narrow focus, however, ignores that if the district court had allowed AmerisourceBergen to amend its reply, as I believe it should have, Dialysist West would not have been entitled to judgment on the pleadings on its second counterclaim because AmerisourceBergen would have been able to dispute the genuineness of the non-Epogen products on which that claim was based. Thus, the majority's assumption that AmerisourceBergen’s only right to payment from Dialysist West was based on setoff is incorrect. AmerisourceBergen's own claims against Dialysist West remained and still remain undetermined, and its ability to collect on those claims, should it ultimately prevail, is jeopardized by Dialysist West's bankruptcy.
